| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 2,215 | 2,415 | 2,508 | 2,522 | 2,582 | 2,850 | 2,922 | 3,125 | 2,179 | 2,808 | 2,781 | 2,931 | 4,079 | 3,725 | 3,662 | 3,580 | 3,812 | 4,274 | 4,299 | 4,322 | 4,452 | 4,873 | 4,880 | 4,981 | 5,134 | 5,633 | 5,596 | 5,664 | 5,896 |
| Expenses | 1,981 | 2,141 | 2,222 | 2,220 | 2,218 | 2,427 | 2,482 | 2,542 | 2,159 | 2,470 | 2,370 | 2,456 | 3,245 | 3,102 | 3,052 | 3,083 | 3,317 | 3,699 | 3,780 | 3,814 | 3,909 | 4,219 | 4,237 | 4,303 | 4,411 | 4,774 | 4,765 | 4,823 | 4,990 |
| EBITDA | 234 | 274 | 286 | 302 | 364 | 423 | 440 | 583 | 21 | 337 | 411 | 475 | 835 | 623 | 610 | 497 | 495 | 575 | 519 | 508 | 543 | 654 | 643 | 677 | 724 | 859 | 831 | 841 | 906 |
| Operating Profit % | 10 % | 11 % | 11 % | 11 % | 14 % | 15 % | 15 % | 13 % | 1 % | 11 % | 14 % | 14 % | 14 % | 17 % | 16 % | 13 % | 13 % | 13 % | 11 % | 11 % | 12 % | 13 % | 13 % | 13 % | 13 % | 15 % | 14 % | 14 % | 15 % |
| Depreciation | 95 | 97 | 98 | 105 | 144 | 155 | 157 | 164 | 160 | 149 | 125 | 139 | 141 | 145 | 149 | 166 | 148 | 155 | 153 | 159 | 167 | 163 | 167 | 190 | 177 | 185 | 185 | 211 | 215 |
| Interest | 76 | 81 | 84 | 85 | 126 | 134 | 137 | 135 | 127 | 122 | 101 | 99 | 95 | 95 | 94 | 95 | 93 | 93 | 100 | 95 | 106 | 111 | 113 | 119 | 116 | 118 | 110 | 115 | 108 |
| Profit Before Tax | 63 | 96 | 103 | 112 | 94 | 134 | 145 | 284 | -267 | 66 | 185 | 238 | 599 | 383 | 368 | 236 | 254 | 327 | 266 | 254 | 270 | 379 | 363 | 368 | 430 | 557 | 536 | 516 | 583 |
| Tax | 39 | 42 | 53 | 39 | 45 | 51 | 55 | 74 | -41 | 7 | 51 | 68 | 99 | 116 | 124 | 139 | -70 | 114 | 104 | 108 | 97 | 130 | 109 | 110 | 115 | 162 | 157 | 101 | 142 |
| Net Profit | 23 | 54 | 50 | 73 | 49 | 83 | 90 | 210 | -226 | 59 | 134 | 170 | 501 | 267 | 243 | 97 | 324 | 213 | 162 | 146 | 173 | 249 | 254 | 258 | 316 | 396 | 379 | 415 | 441 |
| EPS in ₹ | 2.44 | 4.56 | 4.10 | 6.10 | 4.11 | 6.20 | 6.62 | 15.77 | -14.96 | 4.33 | 9.38 | 11.77 | 34.03 | 17.24 | 15.88 | 6.27 | 22.05 | 14.19 | 10.67 | 10.05 | 11.59 | 16.20 | 17.06 | 17.65 | 21.23 | 26.34 | 25.89 | 27.10 | 30.10 |
Apollo Hospitals
Apollo Hospitals
7,804.50
-95.50
(-1.21%)
Market Cap
1,12,216.74 Cr
EPS
100.56
PE Ratio
72.21
Dividend Yield
0.16 %
Industry
Healthcare Services52 Week High
7,980.00
52 Week Low
6,001.00
PB Ratio
13.85
Debt to Equity
0.61
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from26 analysts
Company News
View All News
Apollo Hospitals Schedules Board Meeting for August 13 to Approve Quarterly Financial ResultsToday
Apollo Hospitals Enterprise Limited will hold a Board of Directors meeting on August 13, 2024, to consider approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2024. The company has implemented a trading window closure for promoters, directors, connected persons, and designated employees from July 1, 2024, until 48 hours after the financial results announcement, extending through August 15, 2024.
The GST Council exempted health insurance premiums from indirect tax, which Apollo Hospitals MD Suneeta Reddy says will make insurance more affordable and expand coverage. The broader GST reforms include scrapping 12% and 28% slabs for 5% and 18% rates, with a 40% rate for sin goods. Life-saving cancer and chronic care drugs will have 0% GST instead of 12%, while most other medications will attract 5%. Hospital consumables, diagnostics, reagents, and bandages will move to 5% GST. Construction materials like cement, fly ash, and granite will see rate cuts, potentially lowering hospital infrastructure costs and encouraging capacity expansion. Reddy noted that while hospital bills may not drop immediately due to lack of input tax credit for hospitals, the rationalization of input costs should gradually make healthcare more affordable, with cancer care expected to benefit significantly.
Apollo Hospitals Enterprise Ltd. witnessed a block trade on the National Stock Exchange worth Rs. 60 crores. The transaction involved approximately 76,280 shares at a price of Rs. 7,866 per share.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,170.00 | #1 1,13,741.18 | 94.11 | 7,184.10 | #1 28.68 | 1,076 | 30.34 | 36.88 | |
7,804.50 | #2 1,12,216.74 | #5 72.21 | #1 21,994.30 | #6 14.76 | #1 1,505 | #3 39.78 | 63.94 | |
947.85 | 71,558.71 | 77.62 | 7,849.70 | 13.25 | 809 | #1 53.33 | 65.93 | |
1,408.40 | 37,827.85 | 66.87 | 3,771.40 | 21.40 | 481 | 49.58 | 62.00 | |
1,785.60 | 36,490.67 | 47.45 | 5,575.00 | 12.29 | 790 | -2.38 | 50.57 | |
640.25 | 33,172.70 | 92.17 | 4,286.70 | 15.12 | 337 | -98.18 | 62.15 | |
742.95 | 29,728.32 | 80.33 | 3,067.00 | 21.98 | 415 | -10.71 | 50.13 | |
6,193.50 | 16,350.47 | #1 30.86 | 599.90 | 11.69 | 58 | 24.89 | 47.19 | |
1,510.40 | 15,338.36 | 59.97 | 1,566.90 | 17.46 | 244 | 35.52 | 48.96 | |
690.75 | 9,630.12 | 261.22 | 2,218.14 | 12.97 | 28 | -55.88 | 70.67 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
14.76 %
Net Income Growth
60.97 %
Cash Flow Change
11.26 %
ROE
36.18 %
ROCE
2.58 %
EBITDA Margin (Avg.)
12.43 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 | 20,657 |
| Fixed Assets | 3,244 | 3,997 | 4,591 | 4,773 | 4,982 | 7,432 | 6,778 | 8,296 | 8,520 | 9,664 | 10,988 |
| Current Assets | 1,939 | 1,975 | 2,129 | 2,220 | 2,282 | 2,647 | 3,641 | 4,061 | 4,337 | 5,280 | 7,029 |
| Capital Work in Progress | 533 | 562 | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 873 | 921 |
| Investments | 146 | 352 | 406 | 352 | 462 | 434 | 1,343 | 816 | 574 | 986 | 2,487 |
| Other Assets | 2,557 | 2,448 | 2,775 | 2,776 | 2,918 | 3,237 | 3,062 | 4,112 | 4,725 | 5,230 | 6,261 |
| Total Liabilities | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 | 20,657 |
| Current Liabilities | 1,076 | 1,250 | 963 | 1,567 | 1,956 | 2,337 | 2,038 | 2,434 | 3,325 | 4,665 | 4,579 |
| Non Current Liabilities | 2,159 | 2,701 | 3,718 | 3,662 | 3,759 | 5,531 | 4,577 | 4,932 | 4,572 | 4,768 | 7,426 |
| Total Equity | 3,244 | 3,409 | 3,438 | 3,384 | 3,469 | 3,470 | 4,802 | 5,903 | 6,531 | 7,321 | 8,653 |
| Reserve & Surplus | 3,101 | 3,262 | 3,240 | 3,182 | 3,264 | 3,270 | 4,531 | 5,551 | 6,126 | 6,864 | 8,140 |
| Share Capital | 70 | 70 | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 | 72 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 103 | 39 | -52 | 24 | -20 | 95 | 45 | 158 | -113 | 72 | 73 |
| Investing Activities | -759 | -888 | -1,152 | -405 | -711 | -289 | -880 | -747 | -857 | -1,537 | -3,381 |
| Operating Activities | 470 | 597 | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | 1,920 | 2,136 |
| Financing Activities | 392 | 330 | 477 | -109 | -215 | -910 | -340 | -792 | -633 | -311 | 1,317 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 29.82 % | 29.82 % | 29.82 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.34 % | 29.34 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 45.63 % | 43.92 % | 45.37 % | 45.27 % | 42.74 % | 43.49 % |
| DIIs | 9.16 % | 10.84 % | 12.24 % | 12.13 % | 12.45 % | 14.89 % | 14.59 % | 16.56 % | 17.76 % | 16.31 % | 18.60 % | 17.97 % | 19.55 % | 21.14 % | 19.95 % | 19.98 % | 22.29 % | 21.34 % |
| Government | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % |
| Public / Retail | 4.07 % | 3.99 % | 4.24 % | 4.03 % | 4.27 % | 4.48 % | 4.23 % | 4.13 % | 4.04 % | 3.90 % | 4.04 % | 3.70 % | 3.74 % | 3.81 % | 3.62 % | 3.65 % | 3.81 % | 3.98 % |
| Others | 56.73 % | 55.13 % | 53.47 % | 54.29 % | 53.73 % | 51.07 % | 51.63 % | 49.75 % | 48.64 % | 50.23 % | 47.80 % | 48.76 % | 1.52 % | 1.57 % | 1.50 % | 1.54 % | 1.60 % | 1.62 % |
| No of Share Holders | 67,091 | 75,153 | 98,452 | 99,135 | 1,26,226 | 1,46,320 | 1,35,923 | 1,31,636 | 1,31,937 | 1,20,030 | 1,31,565 | 1,19,578 | 1,30,664 | 1,27,754 | 1,19,245 | 1,27,802 | 1,34,058 | 1,41,007 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 6 | 5 | 6 | 6 | 3 | 11.75 | 15 | 16 | 12.66 |
| Dividend Yield (%) | 0.00 | 0.56 | 0.41 | 0.53 | 0.21 | 0.07 | 0.27 | 0.24 | 0.24 | 0.16 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Aug 2021 |  Dividend | ₹ 3.00 /share | 18 Aug 2021 | 3,244.80 | 4,746.50 |
| 20 Aug 2022 | Dividend | ₹ 11.75 /share | 18 Aug 2022 | 3,524.30 | 4,135.35 |
| 24 Feb 2023 | Dividend | ₹ 6.00 /share | 24 Feb 2023 | 4,355.10 | 4,448.85 |
| 19 Aug 2023 | Dividend | ₹ 9.00 /share | 18 Aug 2023 | 4,646.10 | 4,848.35 |
| 20 Feb 2024 | Dividend | ₹ 6.00 /share | 20 Feb 2024 | 6,179.35 | 6,656.25 |
| 17 Aug 2024 | Dividend | ₹ 10.00 /share | 16 Aug 2024 | 5,903.45 | 6,686.90 |
| 30 Aug 2024 |  Annual General Meeting | NA | 30 Aug 2024 | 6,704.00 | 6,855.95 |
| 06 Nov 2024 |  Quarterly Result Announcement | NA | 06 Nov 2024 | 7,092.60 | 6,966.30 |
| 10 Feb 2025 | Quarterly Result Announcement | NA | 10 Feb 2025 | 6,828.10 | 6,790.55 |
| 15 Feb 2025 | Dividend | ₹ 9.00 /share | 14 Feb 2025 | 6,790.55 | 6,266.65 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 6,974.00 | 6,923.00 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 7,352.50 | 7,259.00 |
| 19 Aug 2025 | Dividend | ₹ 10.00 /share | 19 Aug 2025 | 6,923.00 | 7,822.50 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 6,923.00 | 7,726.60 |
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizers Report
7 days ago
7 days agoShareholder Meeting / Postal Ballot-Outcome of AGM7 days ago
7 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20118 days ago
8 days agoNewspaper Advertisement(S) Regarding Notice Of Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 20, 2025
Aug 20, 2025Update On Outcome Of The Board Meeting - 12Th August 2025Aug 14, 2025
Aug 14, 2025Reply To Your Mail Ref No. L/SURV/ONL/PV/AA/ 2025-2026 / 352 Dated 14Th August 2025Aug 14, 2025
Aug 14, 2025Clarification sought from Apollo Hospitals Enterprise LtdAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 12, 2025
Aug 12, 2025As Per Annexure EnclosedAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-AcquisitionAug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of The Board MeetingAug 12, 2025
Aug 12, 2025Submission Of Newspaper Advertisements - 44Th Annual General Meeting & IEPF Transfer NoticeAug 08, 2025
Aug 08, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 07, 2025
Aug 07, 2025Reg. 34 (1) Annual Report.Aug 06, 2025
Aug 06, 2025Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations)
Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2025
Jul 29, 2025Board Meeting Intimation for Notice For The Board MeetingJul 17, 2025
Jul 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 01, 2025
Jul 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 01, 2025
Jul 01, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Announcement under Regulation 30 (LODR)-AcquisitionJun 10, 2025
Jun 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 06, 2025
Jun 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 31, 2025
May 31, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 31, 2025
May 31, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 31, 2025
May 31, 2025Outcome Of Board Meeting - Appointment Of Secretarial AuditorsMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Date of payment of DividendMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-AcquisitionMay 30, 2025
May 30, 2025AGM On 29Th August 2025May 30, 2025
May 30, 2025Outcome Of Board Meeting - Reappointment Of Executive Directors And Independent DirectorMay 30, 2025
May 30, 2025Fixation Of Record DateMay 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of The Board MeetingMay 30, 2025
May 30, 2025Audited Financial Results For The Quarter And Year Ended 31St March 2025May 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2025
May 20, 2025Merger Of Wholly Owned Subsidiary Of Apollo Hospitals International Limited (AHIL) A Subsidiary Of The Company Into AHIL.May 16, 2025
May 16, 2025Board Meeting Intimation for Notice Of Board MeetingMay 06, 2025
May 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Apr 10, 2025Technical Indicators
RSI(14)
Neutral 63.94
ATR(14)
Volatile 135.92
STOCH(9,6)
Neutral 29.17
STOCH RSI(14)
Neutral 42.56
MACD(12,26)
Bearish -6.55
ADX(14)
Strong Trend 27.80
UO(9)
Bearish 55.08
ROC(12)
Uptrend And Accelerating 0.99
WillR(14)
Neutral -20.30
Mutual Fund Holdings
HDFC Flexi Cap Direct Plan-Growth 
Axis Large Cap Fund Direct-Growth 
Invesco India Contra Fund Direct-Growth 
Mirae Asset Large Cap Fund Direct- Growth 
Nippon India Pharma Fund Direct-Growth 
Franklin India Flexi Cap Fund Direct-Growth 
Aditya Birla Sun Life Large Cap Direct Fund-Growth 
Kotak Arbitrage Fund Direct-Growth 
ICICI Prudential Balanced Advantage Direct-Growth 
DSP India T.I.G.E.R. (The Infrastructure Growth and Economic Reforms Fund) Direct-Growth 
UTI Nifty 50 Index Fund Direct-Growth 
Tata Balanced Advantage Fund Direct - Growth About Apollo Hospitals
Apollo Hospitals Enterprise Limited (AHEL) is a leading private healthcare provider in Asia. It operates a network of hospitals, pharmacies, primary care clinics, and diagnostic centers. As of March 31, 2023, AHEL had a capacity of 9,957 beds across 70 hospitals in India and overseas. This includes 8,544 beds in 43 owned hospitals, 305 beds in 11 cradles, 257 beds in 11 day care/short surgical stay centers, and 851 beds in 5 hospitals operated through management contracts. The company has expanded through acquisitions, joint ventures, and new facility launches. AHEL has also diversified into health insurance, retail pharmacy, and digital healthcare platforms. The company has undergone various corporate restructurings to optimize its business operations across different healthcare segments.
Chairperson NamePreetha Reddy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
